Marcel Schmocker
Direktor/Vorstandsmitglied bei BioXpress Therapeutics SA
Profil
Marcel Schmocker is currently a Director at BioXpress Therapeutics SA and IPRIS AG.
He was formerly a Director at Selexis SA. He received his graduate degree from Duke University in 1986 and his undergraduate degree from the University of Bern in 1983.
Aktive Positionen von Marcel Schmocker
| Unternehmen | Position | Beginn |
|---|---|---|
BioXpress Therapeutics SA
 BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Direktor/Vorstandsmitglied | - |
IPRIS AG
 IPRIS AG Miscellaneous Commercial ServicesCommercial Services IPRIS AG provides intellectual property management solutions. The firm’s offering renewals, European validation, nationalization and renewal portal. The company was founded by Bruno H. Dalle Carbonare and Hugo van Buel in 2004 and is headquartered in Basel, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marcel Schmocker
| Unternehmen | Position | Ende |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Direktor/Vorstandsmitglied | - |
Ausbildung von Marcel Schmocker
| Duke University | Graduate Degree |
| University of Bern | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Health Technology |
IPRIS AG
IPRIS AG Miscellaneous Commercial ServicesCommercial Services IPRIS AG provides intellectual property management solutions. The firm’s offering renewals, European validation, nationalization and renewal portal. The company was founded by Bruno H. Dalle Carbonare and Hugo van Buel in 2004 and is headquartered in Basel, Switzerland. | Commercial Services |
